Taro Pharm Inds (TARO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2018 | 03-2017 | 03-2016 | 03-2015 | 03-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 210,079 | 456,666 | 541,271 | 484,834 | 360,859 |
| Depreciation Amortization | 16,496 | 14,829 | 14,848 | 15,798 | 16,567 |
| Income taxes - deferred | 56,007 | 73,706 | -11,976 | -70,387 | -23,708 |
| Accounts receivable | -277 | 29,584 | -19,895 | -88,783 | -21,312 |
| Accounts payable and accrued liabilities | 9,049 | -2,290 | -679 | -542 | 1,804 |
| Other Working Capital | 7,433 | -80,086 | -137,163 | -9,678 | 10,430 |
| Other Operating Activity | 24,902 | -54,874 | 8,722 | 75,546 | 13,004 |
| Operating Cash Flow | $323,689 | $437,535 | $395,128 | $406,788 | $357,644 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -609,458 | 196,144 | -220,038 | -43,205 | -113,545 |
| PPE Investments | -25,811 | -27,247 | -18,972 | -19,780 | -21,241 |
| Purchase Of Investment | 396,281 | -286,617 | -80,587 | 2,112 | -33,956 |
| Purchase Sale Intangibles | -2,650 | -68 | -134 | -158 | -4,555 |
| Other Investing Activity | -2,650 | -58 | 34,866 | -31,208 | -4,555 |
| Investing Cash Flow | $-241,638 | $-117,778 | $-284,731 | $-92,081 | $-173,297 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -5,888 | -10,944 | -11,874 |
| Common Stock Issued | N/A | N/A | N/A | 26 | 1,262 |
| Common Stock Repurchased | -106,986 | -294,897 | -9,450 | N/A | -192,999 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 149 |
| Financing Cash Flow | $-106,986 | $-294,897 | $-15,338 | $-10,918 | $-203,462 |
| Exchange Rate Effect | 1,147 | -1,218 | 57 | -32,115 | -8,202 |
| Beginning Cash Position | 600,399 | 576,757 | 481,641 | 209,967 | 237,284 |
| End Cash Position | 576,611 | 600,399 | 576,757 | 481,641 | 209,967 |
| Net Cash Flow | $-23,788 | $23,642 | $95,116 | $271,674 | $-27,317 |
| Free Cash Flow | |||||
| Operating Cash Flow | 323,689 | 437,535 | 395,128 | 406,788 | 357,644 |
| Capital Expenditure | -26,886 | -35,755 | -18,972 | -19,997 | -21,249 |
| Free Cash Flow | 296,803 | 401,780 | 376,156 | 386,791 | 336,395 |